DOSSIER · 13F-HR · Q2 2026

FLPUTNAM INVESTMENT MANAGEMENT CO

$8.4B in tracked AUM across 655 positions as of Q2 2026.

FI
CIK 0001140334 · last filed Jun 30, 2026
Total AUM
$8.4B
as of Q2 2026
Holdings
655
positions
Whale Score
61
61
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026

FLPutnam Investment Management's 569-position, index-anchored book fell 2.4% to $6.71 billion this quarter, and most of that decline traces to price, not selling: Microsoft's share count barely moved (-1.5%) but its value in the portfolio dropped $71.6 million as the stock pulled back, and the firm's core S&P 500 ETF (IVV, still the largest position at 12.0% of assets) lost $43 million in value on a nearly flat share count too. Against that market-driven backdrop, one trade stands out as a genuine decision: a brand-new $131.9 million stake in Analog Devices, immediately the seventh-largest position in the entire book and more than 50% larger than any other new position this quarter — a real, sized-up conviction call on a single semiconductor name inside an otherwise diversified, ETF-anchored allocation. Elsewhere, FLPutnam added to Morgan Stanley (+37% shares, $8.4 million) and Eli Lilly (+32% shares, $7.6 million), while fully exiting Netflix ($38.6 million), Apollo Global Management ($33.3 million), Boston Scientific ($32.0 million), and Palo Alto Networks ($31.4 million).

Against that backdrop, one trade reads as a genuine, deliberate decision rather than portfolio drift: a brand-new $131.9 million position in Analog Devices, the semiconductor maker, which entered the book this quarter and immediately became the seventh-largest holding — bigger than JPMorgan, Visa, or Lam Research, and more than 50% larger than any other new position FLPutnam opened. For a firm whose top ten holdings are dominated by broad index ETFs, a single-stock bet of that size is a real statement about where the firm sees value in semiconductors specifically.

The rest of the activity looks like normal rebalancing around the edges. FLPutnam added to Morgan Stanley (+37% in shares, $8.4 million) and Eli Lilly (+32%, $7.6 million), and built out its emerging-markets exposure with a new $84.3 million position in iShares Core MSCI Emerging Markets (IEMG). On the exit side, it fully sold Netflix ($38.6 million), Apollo Global Management ($33.3 million), Boston Scientific ($32.0 million), and Palo Alto Networks ($31.4 million) — four clean, complete exits spanning streaming, alternative asset management, medical devices, and cybersecurity, none individually large enough to be the headline.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
IVV
ISHARES TR
$922M1.2M11.0%
02
IEFA
ISHARES TR
$465M4.8M5.5%
03
NVDA
NVIDIA CORPORATION
$344M1.7M4.1%
04
AAPL
APPLE INC
$303M1.0M3.6%
05
GOOGL
ALPHABET INC
$263M735K3.1%
06
MSFT
MICROSOFT CORP
$234M628K2.8%
07
AVGO
BROADCOM INC
$200M529K2.4%
08
AMZN
AMAZON COM INC
$162M681K1.9%
09
ADI
ANALOG DEVICES INC
$160M403K1.9%
10
MU
MICRON TECHNOLOGY INC
$139M120K1.7%

Filing history

2026Q2Jun 30
$8.4B 25.0%
655 positionsView →
2026Q1Mar 31
$6.7B 2.4%
569 positionsView →
2025Q4Dec 31
$6.9B 2.8%
589 positionsView →
2025Q3Sep 30
$6.7B 14.9%
576 positionsView →
2025Q2Jun 30
$5.8B 9.2%
580 positionsLocked
2025Q1Mar 31
$5.3B 2.5%
564 positionsLocked
2024Q4Dec 31
$5.5B 1.7%
564 positionsLocked
2024Q3Sep 30
$5.6B 4.4%
610 positionsLocked
2024Q2Jun 30
$5.3B 13.5%
728 positionsLocked
2024Q1Mar 31
$4.7B 10.7%
486 positionsLocked
2023Q4Dec 31
$4.2B 17.6%
480 positionsLocked
2023Q3Sep 30
$3.6B 1.8%
466 positionsLocked
Showing 12 of 96